Navigation Links
Abbott Annual Meeting Highlights Continued Strong Performance in 2009; Sustained Growth in 2010
Date:4/23/2010

tin Investment Advisors.
  • William M. Daley, vice chairman and head of the office of corporate responsibility and chairman of the Midwest, JPMorgan Chase & Co.
  • W. James Farrell, retired chairman and chief executive officer, Illinois Tool Works Inc.
  • H. Laurance Fuller, retired co-chairman of the board, BP Amoco, p.l.c.
  • William A. Osborn, retired chairman and chief executive officer, Northern Trust Corporation and The Northern Trust Company.
  • The Rt. Hon. Lord Owen CH FRCP, chairman of Europe Steel, Ltd.
  • Roy S. Roberts, managing director, Reliant Equity Investors.
  • Samuel C. Scott III, retired chairman, president and chief executive officer, Corn Products International, Inc.
  • William D. Smithburg, retired chairman, president and chief executive officer, The Quaker Oats Company.
  • Glenn F. Tilton, chairman, president and chief executive officer, UAL Corporation and United Air Lines, Inc., a wholly owned subsidiary of UAL Corporation.
  • Miles D. White, chairman of the board and chief executive officer, Abbott.

  • W. Ann Reynolds retired from the board of directors after 30 years of service.

    About Abbott

    Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.  The company employs approximately 83,000 people and markets its products in more than 130 countries.

    Abbott's news releases and other info
    '/>"/>

    SOURCE Abbott
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
    2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
    3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
    4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
    5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
    6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
    7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
    8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
    9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
    10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
    11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/4/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/bqfsp3/transdermal_drug ... PharmaBiotech,s new report "Transdermal Drug Delivery ... their offering. This report ... approach used to deliver drugs through the ... to oral,intravascular, subcutaneous and transmucosal routes. Various ...
    (Date:8/4/2015)... 4, 2015 BioElectronics Corporation (OTC Pink: ... Pain Therapy medical devices, announced today that its ... 7-day trial device has been published in the ... http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 chronic ... an assessment.  Chronic pain is ...
    (Date:8/4/2015)... , Aug. 4, 2015  ContraVir Pharmaceuticals, ... focused on the development and commercialization of targeted ... Chief Executive Officer, will present live at VirtualInvestorConferences.com ... August 6, 2015 TIME: 12:15PM EDT LINK: ... a live, interactive online event where investors are ...
    Breaking Medicine Technology:Transdermal Drug Delivery Report 2015-2024 - Technologies, Markets, and Companies Analysis 2BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 3
    ... 5 Transgenomic, Inc. (OTC,Bulletin Board: TBIO), a ... has entered into agreements with two major Pharmaceutical,companies ... $500,000 in the,first half of 2008., "These ... commitments reflect increasing customer validation of our unique,mutation ...
    ... Inc.,(Amex: PLC ), a company focused on innovative ... for the three,and twelve month periods ended December 31, ... compared with,$1,747,000 in the fourth quarter of 2006. The ... or $0.03 per diluted share, compared to net,income of ...
    Cached Medicine Technology:Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies 2PLC Systems Reports Fourth Quarter 2007 Results 2PLC Systems Reports Fourth Quarter 2007 Results 3PLC Systems Reports Fourth Quarter 2007 Results 4PLC Systems Reports Fourth Quarter 2007 Results 5PLC Systems Reports Fourth Quarter 2007 Results 6
    (Date:8/4/2015)... St. Louis, Missouri (PRWEB) , ... August 04, ... ... Automated Texting (IAT) solutions, today announced that Bruce McCalley joins its executive leadership ... 30-year track record of sales success at technology companies and expanding global markets ...
    (Date:8/4/2015)... ... , ... Montclair State University and Atlantic Health System have launched a new ... Jersey, which starting this Fall will help prepare those entering this burgeoning, hybrid field. ... System, one of the largest health care organizations in New Jersey, to design the ...
    (Date:8/4/2015)... ... August 04, 2015 , ... It’s been called “cosmetics ... the customer experience inside Naimie’s Beauty Center in LA. Now MENAJI is part of ... look better. , Naimie’s Beauty Center has been a favorite of makeup artists and ...
    (Date:8/4/2015)... (PRWEB) , ... August 04, ... ... its HealthCenter personal health record (PHR) product has achieved Office of the ... Inpatient EHR Certification from Drummond Group. HealthCenter delivers the highest quality personal ...
    (Date:8/4/2015)... ... August 04, 2015 , ... ... healthcare finance, announced the closing of a $118 million FHA-insured loan modification refinancing ... located in Smithfield and Clayton, North Carolina. JHSC is a joint venture ...
    Breaking Medicine News(10 mins):Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3Health News:MENAJI Shines in Make-Up Mecca for Stars 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 3Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 2Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 3
    ... Additional beneficial effects on cardiometabolic risk factors beyond those ... drug rimonabant may not be due to the drug ... Drug and Therapeutics Bulletin (DTB). ,Advertisements ... Sanofi-Aventis) claim that an estimated 50% of the effects ...
    ... Cryo-Save Group NV together with the University of Cologne ... collect adult mesenchymal stem cells ("MSCs") from the ... allows the collection and cryopreservation of very high quantities ... ,Mesenchymal stem cells (MSCs) are of great therapeutic ...
    ... current rehab spell will bring a stop to her suicidal ... ,As the Mean Girls star checked into the Promises ... arrested for DUI, her supposed friends got ready to reveal ... America's Star magazine that Lohan attempted to take her own ...
    ... to enter rehab in order to get rid of his addiction ... was recently snapped in a sleazy romp with two hookers, admitted ... ,"Im a bad boy. I go out and get drunk, ... with the wrong women. Ive been sowing my oats for years, ...
    ... unabated across the Atlantic. But the man who set off ... Denver that specializes in the disease. The man himself ... Atlanta. He is not coughing, has no fever and does ... said. ,Still, staff at the National Jewish Medical ...
    ... double current funding levels for the President's Emergency Plan ... years after the program's original mandate expires next year, ... $15 billion over five years for HIV/AIDS and tuberculosis ... the Global Fund To Fight AIDS, Tuberculosis and Malaria. ...
    Cached Medicine News:Health News:Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned 2Health News:Significant Scientific Breakthrough in Stem Cell Banking 2Health News:American Who Set Off TB Scare Doing Well in Hospital 2Health News:American Who Set Off TB Scare Doing Well in Hospital 3Health News:Bush Announces Request for $30B, Five-Year Extension of PEPFAR 2
    ... the latest technology and innovative software with ... transmission and auto detection of progressive lenses. ... network with the VELO 8500 Motorized Refractor ... the future. , ,*VELOtm Aculens 186UV can ...
    ...
    ...
    ...
    Medicine Products: